nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—hypertension—obesity	0.646	1	CtDrD
Candesartan—CYP2C8—Bupropion—obesity	0.0425	0.235	CbGbCtD
Candesartan—CYP2C9—Phentermine—obesity	0.0349	0.193	CbGbCtD
Candesartan—CYP2C8—Cimetidine—obesity	0.0312	0.172	CbGbCtD
Candesartan—CYP2C9—Bupropion—obesity	0.0296	0.164	CbGbCtD
Candesartan—CYP2C9—Cimetidine—obesity	0.0217	0.12	CbGbCtD
Candesartan—ABCB1—Cimetidine—obesity	0.0211	0.117	CbGbCtD
Candesartan—UGT1A3—digestive system—obesity	0.000978	0.103	CbGeAlD
Candesartan—UGT1A3—endocrine gland—obesity	0.000808	0.085	CbGeAlD
Candesartan—UGT1A3—liver—obesity	0.000728	0.0766	CbGeAlD
Candesartan—AGTR1—adrenal cortex—obesity	0.00055	0.0579	CbGeAlD
Candesartan—Pranlukast—TNF—obesity	0.000511	0.359	CrCbGaD
Candesartan—AGTR1—cardiovascular system—obesity	0.000502	0.0528	CbGeAlD
Candesartan—AGTR1—pituitary gland—obesity	0.000445	0.0468	CbGeAlD
Candesartan—AGTR1—adipose tissue—obesity	0.000443	0.0466	CbGeAlD
Candesartan—Telmisartan—PPARG—obesity	0.00044	0.309	CrCbGaD
Candesartan—AGTR1—adrenal gland—obesity	0.000397	0.0418	CbGeAlD
Candesartan—Diarrhoea—Phendimetrazine—obesity	0.000388	0.00429	CcSEcCtD
Candesartan—Thrombocytopenia—Cimetidine—obesity	0.000376	0.00415	CcSEcCtD
Candesartan—Dizziness—Phendimetrazine—obesity	0.000375	0.00414	CcSEcCtD
Candesartan—Tachycardia—Cimetidine—obesity	0.000375	0.00414	CcSEcCtD
Candesartan—Nausea—Benzphetamine—obesity	0.00037	0.00408	CcSEcCtD
Candesartan—Urticaria—Phentermine—obesity	0.000369	0.00407	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Diethylpropion—obesity	0.000368	0.00406	CcSEcCtD
Candesartan—Abdominal pain—Phentermine—obesity	0.000367	0.00405	CcSEcCtD
Candesartan—Sweating increased—Orlistat—obesity	0.000363	0.00401	CcSEcCtD
Candesartan—Dyspnoea—Diethylpropion—obesity	0.00036	0.00397	CcSEcCtD
Candesartan—Somnolence—Diethylpropion—obesity	0.000359	0.00396	CcSEcCtD
Candesartan—Headache—Phendimetrazine—obesity	0.000356	0.00392	CcSEcCtD
Candesartan—Dyspepsia—Diethylpropion—obesity	0.000355	0.00392	CcSEcCtD
Candesartan—Angina pectoris—Sibutramine—obesity	0.000352	0.00388	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Cimetidine—obesity	0.00035	0.00386	CcSEcCtD
Candesartan—Gastrointestinal disorder—Diethylpropion—obesity	0.000349	0.00385	CcSEcCtD
Candesartan—Bronchitis—Sibutramine—obesity	0.000347	0.00383	CcSEcCtD
Candesartan—Upper respiratory tract infection—Orlistat—obesity	0.000347	0.00382	CcSEcCtD
Candesartan—AGTR1—endocrine gland—obesity	0.000344	0.0362	CbGeAlD
Candesartan—Somnolence—Cimetidine—obesity	0.000341	0.00377	CcSEcCtD
Candesartan—Nausea—Phendimetrazine—obesity	0.000337	0.00372	CcSEcCtD
Candesartan—Asthenia—Phentermine—obesity	0.000333	0.00367	CcSEcCtD
Candesartan—Fatigue—Cimetidine—obesity	0.000331	0.00365	CcSEcCtD
Candesartan—Renal failure—Orlistat—obesity	0.000327	0.00361	CcSEcCtD
Candesartan—Hyperglycaemia—Sibutramine—obesity	0.000326	0.00359	CcSEcCtD
Candesartan—Urticaria—Diethylpropion—obesity	0.000321	0.00354	CcSEcCtD
Candesartan—Dizziness—Phenylpropanolamine—obesity	0.000321	0.00354	CcSEcCtD
Candesartan—Diarrhoea—Phentermine—obesity	0.000318	0.0035	CcSEcCtD
Candesartan—Acute coronary syndrome—Sibutramine—obesity	0.000317	0.0035	CcSEcCtD
Candesartan—Renal failure—Sibutramine—obesity	0.000316	0.00349	CcSEcCtD
Candesartan—Myocardial infarction—Sibutramine—obesity	0.000315	0.00348	CcSEcCtD
Candesartan—Sinusitis—Orlistat—obesity	0.000312	0.00344	CcSEcCtD
Candesartan—AGTR1—liver—obesity	0.00031	0.0327	CbGeAlD
Candesartan—Vomiting—Phenylpropanolamine—obesity	0.000308	0.0034	CcSEcCtD
Candesartan—Dizziness—Phentermine—obesity	0.000307	0.00339	CcSEcCtD
Candesartan—Haematuria—Sibutramine—obesity	0.000307	0.00339	CcSEcCtD
Candesartan—Sweating increased—Bupropion—obesity	0.000306	0.00338	CcSEcCtD
Candesartan—Rash—Phenylpropanolamine—obesity	0.000306	0.00337	CcSEcCtD
Candesartan—Dermatitis—Phenylpropanolamine—obesity	0.000305	0.00337	CcSEcCtD
Candesartan—Body temperature increased—Cimetidine—obesity	0.000304	0.00335	CcSEcCtD
Candesartan—Epistaxis—Sibutramine—obesity	0.000304	0.00335	CcSEcCtD
Candesartan—Bronchitis—Bupropion—obesity	0.000303	0.00334	CcSEcCtD
Candesartan—Sinusitis—Sibutramine—obesity	0.000302	0.00333	CcSEcCtD
Candesartan—Haemoglobin—Orlistat—obesity	0.0003	0.00331	CcSEcCtD
Candesartan—Haemorrhage—Orlistat—obesity	0.000299	0.00329	CcSEcCtD
Candesartan—Hepatitis—Orlistat—obesity	0.000299	0.00329	CcSEcCtD
Candesartan—Pharyngitis—Orlistat—obesity	0.000296	0.00327	CcSEcCtD
Candesartan—Vomiting—Phentermine—obesity	0.000295	0.00326	CcSEcCtD
Candesartan—Urinary tract disorder—Orlistat—obesity	0.000295	0.00325	CcSEcCtD
Candesartan—Oedema peripheral—Orlistat—obesity	0.000294	0.00324	CcSEcCtD
Candesartan—Urethral disorder—Orlistat—obesity	0.000293	0.00323	CcSEcCtD
Candesartan—Rash—Phentermine—obesity	0.000293	0.00323	CcSEcCtD
Candesartan—Upper respiratory tract infection—Bupropion—obesity	0.000292	0.00323	CcSEcCtD
Candesartan—Dermatitis—Phentermine—obesity	0.000292	0.00323	CcSEcCtD
Candesartan—Headache—Phentermine—obesity	0.000291	0.00321	CcSEcCtD
Candesartan—Haemoglobin—Sibutramine—obesity	0.00029	0.0032	CcSEcCtD
Candesartan—Rhinitis—Sibutramine—obesity	0.00029	0.0032	CcSEcCtD
Candesartan—Haemorrhage—Sibutramine—obesity	0.000289	0.00319	CcSEcCtD
Candesartan—PTGS1—respiratory system—obesity	0.000288	0.0303	CbGeAlD
Candesartan—Nausea—Phenylpropanolamine—obesity	0.000288	0.00318	CcSEcCtD
Candesartan—Pharyngitis—Sibutramine—obesity	0.000287	0.00316	CcSEcCtD
Candesartan—Oedema peripheral—Sibutramine—obesity	0.000285	0.00314	CcSEcCtD
Candesartan—Hyperglycaemia—Bupropion—obesity	0.000284	0.00313	CcSEcCtD
Candesartan—Acute coronary syndrome—Bupropion—obesity	0.000277	0.00305	CcSEcCtD
Candesartan—Diarrhoea—Diethylpropion—obesity	0.000276	0.00305	CcSEcCtD
Candesartan—Nausea—Phentermine—obesity	0.000276	0.00304	CcSEcCtD
Candesartan—Asthenia—Cimetidine—obesity	0.000276	0.00304	CcSEcCtD
Candesartan—Myocardial infarction—Bupropion—obesity	0.000275	0.00303	CcSEcCtD
Candesartan—Dizziness—Diethylpropion—obesity	0.000267	0.00295	CcSEcCtD
Candesartan—Epistaxis—Bupropion—obesity	0.000265	0.00292	CcSEcCtD
Candesartan—Sinusitis—Bupropion—obesity	0.000263	0.0029	CcSEcCtD
Candesartan—Diarrhoea—Cimetidine—obesity	0.000263	0.0029	CcSEcCtD
Candesartan—Gastroenteritis—Topiramate—obesity	0.000262	0.00289	CcSEcCtD
Candesartan—Mental disorder—Orlistat—obesity	0.000262	0.00289	CcSEcCtD
Candesartan—Malnutrition—Orlistat—obesity	0.00026	0.00287	CcSEcCtD
Candesartan—Vomiting—Diethylpropion—obesity	0.000257	0.00283	CcSEcCtD
Candesartan—Rash—Diethylpropion—obesity	0.000255	0.00281	CcSEcCtD
Candesartan—Dermatitis—Diethylpropion—obesity	0.000254	0.00281	CcSEcCtD
Candesartan—Dizziness—Cimetidine—obesity	0.000254	0.0028	CcSEcCtD
Candesartan—Haemoglobin—Bupropion—obesity	0.000253	0.00279	CcSEcCtD
Candesartan—Headache—Diethylpropion—obesity	0.000253	0.00279	CcSEcCtD
Candesartan—Rhinitis—Bupropion—obesity	0.000252	0.00279	CcSEcCtD
Candesartan—Hepatitis—Bupropion—obesity	0.000252	0.00278	CcSEcCtD
Candesartan—Haemorrhage—Bupropion—obesity	0.000252	0.00278	CcSEcCtD
Candesartan—Malnutrition—Sibutramine—obesity	0.000251	0.00278	CcSEcCtD
Candesartan—Back pain—Orlistat—obesity	0.000251	0.00277	CcSEcCtD
Candesartan—Pharyngitis—Bupropion—obesity	0.00025	0.00276	CcSEcCtD
Candesartan—Urinary tract disorder—Bupropion—obesity	0.000249	0.00274	CcSEcCtD
Candesartan—Oedema peripheral—Bupropion—obesity	0.000248	0.00274	CcSEcCtD
Candesartan—Urethral disorder—Bupropion—obesity	0.000247	0.00272	CcSEcCtD
Candesartan—Vomiting—Cimetidine—obesity	0.000244	0.0027	CcSEcCtD
Candesartan—Back pain—Sibutramine—obesity	0.000243	0.00268	CcSEcCtD
Candesartan—Rash—Cimetidine—obesity	0.000242	0.00267	CcSEcCtD
Candesartan—Dermatitis—Cimetidine—obesity	0.000242	0.00267	CcSEcCtD
Candesartan—CYP2C9—cardiovascular system—obesity	0.000242	0.0254	CbGeAlD
Candesartan—CYP2C8—pituitary gland—obesity	0.000241	0.0254	CbGeAlD
Candesartan—Headache—Cimetidine—obesity	0.000241	0.00266	CcSEcCtD
Candesartan—Nausea—Diethylpropion—obesity	0.00024	0.00265	CcSEcCtD
Candesartan—Angioedema—Orlistat—obesity	0.000237	0.00262	CcSEcCtD
Candesartan—Vertigo—Orlistat—obesity	0.000233	0.00258	CcSEcCtD
Candesartan—Hyponatraemia—Topiramate—obesity	0.000233	0.00257	CcSEcCtD
Candesartan—Anaemia—Sibutramine—obesity	0.000232	0.00256	CcSEcCtD
Candesartan—Angioedema—Sibutramine—obesity	0.00023	0.00254	CcSEcCtD
Candesartan—Palpitations—Orlistat—obesity	0.00023	0.00253	CcSEcCtD
Candesartan—Nausea—Cimetidine—obesity	0.000228	0.00252	CcSEcCtD
Candesartan—Cough—Orlistat—obesity	0.000227	0.0025	CcSEcCtD
Candesartan—Vertigo—Sibutramine—obesity	0.000226	0.00249	CcSEcCtD
Candesartan—Leukopenia—Sibutramine—obesity	0.000225	0.00248	CcSEcCtD
Candesartan—Palpitations—Sibutramine—obesity	0.000222	0.00245	CcSEcCtD
Candesartan—Myalgia—Orlistat—obesity	0.000221	0.00244	CcSEcCtD
Candesartan—Chest pain—Orlistat—obesity	0.000221	0.00244	CcSEcCtD
Candesartan—PTGS1—cardiovascular system—obesity	0.000221	0.0232	CbGeAlD
Candesartan—Mental disorder—Bupropion—obesity	0.000221	0.00243	CcSEcCtD
Candesartan—Anxiety—Orlistat—obesity	0.00022	0.00243	CcSEcCtD
Candesartan—Cough—Sibutramine—obesity	0.000219	0.00242	CcSEcCtD
Candesartan—Malnutrition—Bupropion—obesity	0.000219	0.00242	CcSEcCtD
Candesartan—Blood creatinine increased—Topiramate—obesity	0.000217	0.0024	CcSEcCtD
Candesartan—Hypertension—Sibutramine—obesity	0.000217	0.0024	CcSEcCtD
Candesartan—Myalgia—Sibutramine—obesity	0.000214	0.00236	CcSEcCtD
Candesartan—Arthralgia—Sibutramine—obesity	0.000214	0.00236	CcSEcCtD
Candesartan—Chest pain—Sibutramine—obesity	0.000214	0.00236	CcSEcCtD
Candesartan—Anxiety—Sibutramine—obesity	0.000213	0.00235	CcSEcCtD
Candesartan—Back pain—Bupropion—obesity	0.000212	0.00234	CcSEcCtD
Candesartan—Losartan—ACE—obesity	0.00021	0.148	CrCbGaD
Candesartan—Hyperhidrosis—Orlistat—obesity	0.000205	0.00226	CcSEcCtD
Candesartan—Anaemia—Bupropion—obesity	0.000203	0.00224	CcSEcCtD
Candesartan—Thrombocytopenia—Sibutramine—obesity	0.000201	0.00222	CcSEcCtD
Candesartan—CYP2C9—digestive system—obesity	0.000201	0.0211	CbGeAlD
Candesartan—Angioedema—Bupropion—obesity	0.0002	0.00221	CcSEcCtD
Candesartan—Tachycardia—Sibutramine—obesity	0.0002	0.00221	CcSEcCtD
Candesartan—Hyperhidrosis—Sibutramine—obesity	0.000198	0.00219	CcSEcCtD
Candesartan—Vertigo—Bupropion—obesity	0.000197	0.00217	CcSEcCtD
Candesartan—Leukopenia—Bupropion—obesity	0.000196	0.00217	CcSEcCtD
Candesartan—PTGS1—pituitary gland—obesity	0.000195	0.0206	CbGeAlD
Candesartan—Angina pectoris—Topiramate—obesity	0.000195	0.00215	CcSEcCtD
Candesartan—Sweating increased—Topiramate—obesity	0.000195	0.00215	CcSEcCtD
Candesartan—PTGS1—adipose tissue—obesity	0.000195	0.0205	CbGeAlD
Candesartan—Palpitations—Bupropion—obesity	0.000194	0.00214	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Orlistat—obesity	0.000193	0.00213	CcSEcCtD
Candesartan—Bronchitis—Topiramate—obesity	0.000193	0.00213	CcSEcCtD
Candesartan—Hypotension—Sibutramine—obesity	0.000192	0.00212	CcSEcCtD
Candesartan—Cough—Bupropion—obesity	0.000191	0.00211	CcSEcCtD
Candesartan—Paraesthesia—Orlistat—obesity	0.00019	0.0021	CcSEcCtD
Candesartan—Hypertension—Bupropion—obesity	0.000189	0.00209	CcSEcCtD
Candesartan—Neutropenia—Topiramate—obesity	0.000187	0.00207	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Sibutramine—obesity	0.000187	0.00206	CcSEcCtD
Candesartan—CYP2C8—endocrine gland—obesity	0.000187	0.0196	CbGeAlD
Candesartan—Dyspepsia—Orlistat—obesity	0.000187	0.00206	CcSEcCtD
Candesartan—Arthralgia—Bupropion—obesity	0.000187	0.00206	CcSEcCtD
Candesartan—Chest pain—Bupropion—obesity	0.000187	0.00206	CcSEcCtD
Candesartan—Myalgia—Bupropion—obesity	0.000187	0.00206	CcSEcCtD
Candesartan—Upper respiratory tract infection—Topiramate—obesity	0.000186	0.00206	CcSEcCtD
Candesartan—Anxiety—Bupropion—obesity	0.000186	0.00205	CcSEcCtD
Candesartan—Paraesthesia—Sibutramine—obesity	0.000184	0.00203	CcSEcCtD
Candesartan—PTGS1—digestive system—obesity	0.000183	0.0193	CbGeAlD
Candesartan—Gastrointestinal disorder—Orlistat—obesity	0.000183	0.00202	CcSEcCtD
Candesartan—Dyspnoea—Sibutramine—obesity	0.000183	0.00202	CcSEcCtD
Candesartan—Fatigue—Orlistat—obesity	0.000183	0.00202	CcSEcCtD
Candesartan—Somnolence—Sibutramine—obesity	0.000182	0.00201	CcSEcCtD
Candesartan—Hyperglycaemia—Topiramate—obesity	0.000181	0.002	CcSEcCtD
Candesartan—Dyspepsia—Sibutramine—obesity	0.000181	0.00199	CcSEcCtD
Candesartan—ABCB1—islet of Langerhans—obesity	0.00018	0.019	CbGeAlD
Candesartan—Gastrointestinal disorder—Sibutramine—obesity	0.000177	0.00196	CcSEcCtD
Candesartan—Valsartan—ALB—obesity	0.000176	0.124	CrCbGaD
Candesartan—Renal failure—Topiramate—obesity	0.000176	0.00194	CcSEcCtD
Candesartan—Thrombocytopenia—Bupropion—obesity	0.000175	0.00193	CcSEcCtD
Candesartan—Tachycardia—Bupropion—obesity	0.000175	0.00193	CcSEcCtD
Candesartan—PTGS1—adrenal gland—obesity	0.000175	0.0184	CbGeAlD
Candesartan—Gastrointestinal pain—Orlistat—obesity	0.000173	0.00191	CcSEcCtD
Candesartan—Hyperhidrosis—Bupropion—obesity	0.000173	0.00191	CcSEcCtD
Candesartan—Haematuria—Topiramate—obesity	0.00017	0.00188	CcSEcCtD
Candesartan—ABCB1—respiratory system—obesity	0.00017	0.0179	CbGeAlD
Candesartan—Epistaxis—Topiramate—obesity	0.000169	0.00186	CcSEcCtD
Candesartan—Urticaria—Orlistat—obesity	0.000168	0.00186	CcSEcCtD
Candesartan—CYP2C8—liver—obesity	0.000168	0.0177	CbGeAlD
Candesartan—Gastrointestinal pain—Sibutramine—obesity	0.000168	0.00185	CcSEcCtD
Candesartan—Sinusitis—Topiramate—obesity	0.000168	0.00185	CcSEcCtD
Candesartan—Abdominal pain—Orlistat—obesity	0.000168	0.00185	CcSEcCtD
Candesartan—Body temperature increased—Orlistat—obesity	0.000168	0.00185	CcSEcCtD
Candesartan—Hypotension—Bupropion—obesity	0.000167	0.00184	CcSEcCtD
Candesartan—Agranulocytosis—Topiramate—obesity	0.000167	0.00184	CcSEcCtD
Candesartan—CYP2C9—endocrine gland—obesity	0.000166	0.0174	CbGeAlD
Candesartan—Urticaria—Sibutramine—obesity	0.000163	0.0018	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Bupropion—obesity	0.000163	0.0018	CcSEcCtD
Candesartan—Body temperature increased—Sibutramine—obesity	0.000162	0.00179	CcSEcCtD
Candesartan—Abdominal pain—Sibutramine—obesity	0.000162	0.00179	CcSEcCtD
Candesartan—Haemoglobin—Topiramate—obesity	0.000161	0.00178	CcSEcCtD
Candesartan—Rhinitis—Topiramate—obesity	0.000161	0.00178	CcSEcCtD
Candesartan—Paraesthesia—Bupropion—obesity	0.000161	0.00177	CcSEcCtD
Candesartan—Haemorrhage—Topiramate—obesity	0.00016	0.00177	CcSEcCtD
Candesartan—Hepatitis—Topiramate—obesity	0.00016	0.00177	CcSEcCtD
Candesartan—Dyspnoea—Bupropion—obesity	0.00016	0.00176	CcSEcCtD
Candesartan—Pharyngitis—Topiramate—obesity	0.000159	0.00176	CcSEcCtD
Candesartan—Somnolence—Bupropion—obesity	0.000159	0.00176	CcSEcCtD
Candesartan—Urinary tract disorder—Topiramate—obesity	0.000158	0.00175	CcSEcCtD
Candesartan—Oedema peripheral—Topiramate—obesity	0.000158	0.00174	CcSEcCtD
Candesartan—Dyspepsia—Bupropion—obesity	0.000158	0.00174	CcSEcCtD
Candesartan—Urethral disorder—Topiramate—obesity	0.000157	0.00174	CcSEcCtD
Candesartan—Gastrointestinal disorder—Bupropion—obesity	0.000154	0.0017	CcSEcCtD
Candesartan—Fatigue—Bupropion—obesity	0.000154	0.0017	CcSEcCtD
Candesartan—Asthenia—Orlistat—obesity	0.000152	0.00168	CcSEcCtD
Candesartan—PTGS1—endocrine gland—obesity	0.000151	0.0159	CbGeAlD
Candesartan—Pruritus—Orlistat—obesity	0.00015	0.00166	CcSEcCtD
Candesartan—CYP2C9—liver—obesity	0.00015	0.0157	CbGeAlD
Candesartan—Asthenia—Sibutramine—obesity	0.000147	0.00162	CcSEcCtD
Candesartan—Gastrointestinal pain—Bupropion—obesity	0.000146	0.00161	CcSEcCtD
Candesartan—Pruritus—Sibutramine—obesity	0.000145	0.0016	CcSEcCtD
Candesartan—Diarrhoea—Orlistat—obesity	0.000145	0.0016	CcSEcCtD
Candesartan—ABCB1—adrenal cortex—obesity	0.000143	0.015	CbGeAlD
Candesartan—Urticaria—Bupropion—obesity	0.000142	0.00157	CcSEcCtD
Candesartan—Abdominal pain—Bupropion—obesity	0.000141	0.00156	CcSEcCtD
Candesartan—Body temperature increased—Bupropion—obesity	0.000141	0.00156	CcSEcCtD
Candesartan—Mental disorder—Topiramate—obesity	0.000141	0.00155	CcSEcCtD
Candesartan—Diarrhoea—Sibutramine—obesity	0.00014	0.00155	CcSEcCtD
Candesartan—Dizziness—Orlistat—obesity	0.00014	0.00155	CcSEcCtD
Candesartan—Malnutrition—Topiramate—obesity	0.00014	0.00154	CcSEcCtD
Candesartan—Dizziness—Sibutramine—obesity	0.000136	0.0015	CcSEcCtD
Candesartan—Back pain—Topiramate—obesity	0.000135	0.00149	CcSEcCtD
Candesartan—Vomiting—Orlistat—obesity	0.000135	0.00149	CcSEcCtD
Candesartan—Rash—Orlistat—obesity	0.000134	0.00148	CcSEcCtD
Candesartan—Dermatitis—Orlistat—obesity	0.000134	0.00147	CcSEcCtD
Candesartan—Headache—Orlistat—obesity	0.000133	0.00147	CcSEcCtD
Candesartan—ABCB1—cardiovascular system—obesity	0.00013	0.0137	CbGeAlD
Candesartan—Vomiting—Sibutramine—obesity	0.00013	0.00144	CcSEcCtD
Candesartan—Rash—Sibutramine—obesity	0.000129	0.00143	CcSEcCtD
Candesartan—Dermatitis—Sibutramine—obesity	0.000129	0.00143	CcSEcCtD
Candesartan—Anaemia—Topiramate—obesity	0.000129	0.00142	CcSEcCtD
Candesartan—Headache—Sibutramine—obesity	0.000129	0.00142	CcSEcCtD
Candesartan—Asthenia—Bupropion—obesity	0.000128	0.00142	CcSEcCtD
Candesartan—Pruritus—Bupropion—obesity	0.000127	0.0014	CcSEcCtD
Candesartan—Nausea—Orlistat—obesity	0.000126	0.00139	CcSEcCtD
Candesartan—Vertigo—Topiramate—obesity	0.000125	0.00138	CcSEcCtD
Candesartan—Leukopenia—Topiramate—obesity	0.000125	0.00138	CcSEcCtD
Candesartan—Palpitations—Topiramate—obesity	0.000123	0.00136	CcSEcCtD
Candesartan—Diarrhoea—Bupropion—obesity	0.000122	0.00135	CcSEcCtD
Candesartan—Nausea—Sibutramine—obesity	0.000122	0.00135	CcSEcCtD
Candesartan—Cough—Topiramate—obesity	0.000122	0.00134	CcSEcCtD
Candesartan—Hypertension—Topiramate—obesity	0.000121	0.00133	CcSEcCtD
Candesartan—Chest pain—Topiramate—obesity	0.000119	0.00131	CcSEcCtD
Candesartan—Arthralgia—Topiramate—obesity	0.000119	0.00131	CcSEcCtD
Candesartan—Myalgia—Topiramate—obesity	0.000119	0.00131	CcSEcCtD
Candesartan—Anxiety—Topiramate—obesity	0.000119	0.00131	CcSEcCtD
Candesartan—Dizziness—Bupropion—obesity	0.000118	0.00131	CcSEcCtD
Candesartan—ABCB1—pituitary gland—obesity	0.000116	0.0122	CbGeAlD
Candesartan—ABCB1—adipose tissue—obesity	0.000115	0.0121	CbGeAlD
Candesartan—Vomiting—Bupropion—obesity	0.000114	0.00126	CcSEcCtD
Candesartan—Rash—Bupropion—obesity	0.000113	0.00124	CcSEcCtD
Candesartan—Dermatitis—Bupropion—obesity	0.000113	0.00124	CcSEcCtD
Candesartan—Headache—Bupropion—obesity	0.000112	0.00124	CcSEcCtD
Candesartan—Thrombocytopenia—Topiramate—obesity	0.000112	0.00123	CcSEcCtD
Candesartan—Tachycardia—Topiramate—obesity	0.000111	0.00123	CcSEcCtD
Candesartan—Hyperhidrosis—Topiramate—obesity	0.00011	0.00122	CcSEcCtD
Candesartan—ABCB1—digestive system—obesity	0.000108	0.0114	CbGeAlD
Candesartan—Hypotension—Topiramate—obesity	0.000107	0.00118	CcSEcCtD
Candesartan—Nausea—Bupropion—obesity	0.000106	0.00117	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Topiramate—obesity	0.000104	0.00115	CcSEcCtD
Candesartan—ABCB1—adrenal gland—obesity	0.000103	0.0109	CbGeAlD
Candesartan—Paraesthesia—Topiramate—obesity	0.000102	0.00113	CcSEcCtD
Candesartan—Dyspnoea—Topiramate—obesity	0.000102	0.00112	CcSEcCtD
Candesartan—Somnolence—Topiramate—obesity	0.000101	0.00112	CcSEcCtD
Candesartan—Dyspepsia—Topiramate—obesity	0.0001	0.00111	CcSEcCtD
Candesartan—Gastrointestinal disorder—Topiramate—obesity	9.84e-05	0.00109	CcSEcCtD
Candesartan—Fatigue—Topiramate—obesity	9.83e-05	0.00108	CcSEcCtD
Candesartan—Gastrointestinal pain—Topiramate—obesity	9.32e-05	0.00103	CcSEcCtD
Candesartan—Urticaria—Topiramate—obesity	9.06e-05	0.000999	CcSEcCtD
Candesartan—Abdominal pain—Topiramate—obesity	9.01e-05	0.000994	CcSEcCtD
Candesartan—Body temperature increased—Topiramate—obesity	9.01e-05	0.000994	CcSEcCtD
Candesartan—ABCB1—endocrine gland—obesity	8.95e-05	0.00942	CbGeAlD
Candesartan—Losartan—ALB—obesity	8.6e-05	0.0604	CrCbGaD
Candesartan—Asthenia—Topiramate—obesity	8.18e-05	0.000903	CcSEcCtD
Candesartan—ABCB1—liver—obesity	8.07e-05	0.00849	CbGeAlD
Candesartan—Pruritus—Topiramate—obesity	8.07e-05	0.00089	CcSEcCtD
Candesartan—Diarrhoea—Topiramate—obesity	7.8e-05	0.000861	CcSEcCtD
Candesartan—Dizziness—Topiramate—obesity	7.54e-05	0.000832	CcSEcCtD
Candesartan—Vomiting—Topiramate—obesity	7.25e-05	0.0008	CcSEcCtD
Candesartan—Rash—Topiramate—obesity	7.19e-05	0.000793	CcSEcCtD
Candesartan—Dermatitis—Topiramate—obesity	7.18e-05	0.000792	CcSEcCtD
Candesartan—Headache—Topiramate—obesity	7.14e-05	0.000788	CcSEcCtD
Candesartan—Nausea—Topiramate—obesity	6.77e-05	0.000747	CcSEcCtD
Candesartan—ABCB1—Metabolism—APOA5—obesity	6.47e-06	9.06e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1—obesity	6.46e-06	9.04e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT2—obesity	6.45e-06	9.03e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GNB3—obesity	6.39e-06	8.94e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARGC1A—obesity	6.39e-06	8.94e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—obesity	6.38e-06	8.93e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HMOX1—obesity	6.36e-06	8.9e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CPT1A—obesity	6.32e-06	8.84e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPA—obesity	6.31e-06	8.83e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GNAS—obesity	6.22e-06	8.7e-05	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	6.22e-06	8.7e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CD—obesity	6.2e-06	8.68e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NAMPT—obesity	6.2e-06	8.67e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC22A1—obesity	6.17e-06	8.64e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CLOCK—obesity	6.17e-06	8.64e-05	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PPARA—obesity	6.17e-06	8.64e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPIN1—obesity	6.17e-06	8.64e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—obesity	6.16e-06	8.62e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GCK—obesity	6.16e-06	8.61e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LIPC—obesity	6.16e-06	8.61e-05	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CA—obesity	6.14e-06	8.6e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SERPINE1—obesity	6.13e-06	8.58e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOC3—obesity	6.12e-06	8.56e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOB—obesity	6.09e-06	8.52e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—obesity	6.07e-06	8.5e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—obesity	6.06e-06	8.49e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA5—obesity	6.05e-06	8.46e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SULT2A1—obesity	6.02e-06	8.42e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GLP1R—obesity	6.02e-06	8.42e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CB—obesity	5.99e-06	8.38e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TYK2—obesity	5.97e-06	8.35e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CETP—obesity	5.94e-06	8.31e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—obesity	5.93e-06	8.3e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—DPYD—obesity	5.92e-06	8.28e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RHOA—obesity	5.92e-06	8.28e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—obesity	5.87e-06	8.22e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SDC1—obesity	5.87e-06	8.22e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3R1—obesity	5.86e-06	8.19e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOS3—obesity	5.86e-06	8.19e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LPL—obesity	5.82e-06	8.14e-05	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	5.79e-06	8.1e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKR1C3—obesity	5.78e-06	8.09e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC22A1—obesity	5.77e-06	8.07e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CLOCK—obesity	5.77e-06	8.07e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—obesity	5.75e-06	8.05e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—obesity	5.7e-06	7.98e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PRKAR2B—obesity	5.7e-06	7.97e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—obesity	5.69e-06	7.96e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SCARB1—obesity	5.69e-06	7.96e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPX1—obesity	5.67e-06	7.94e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—DCN—obesity	5.66e-06	7.92e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SULT2A1—obesity	5.62e-06	7.87e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GLP1R—obesity	5.62e-06	7.87e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—obesity	5.61e-06	7.85e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CA—obesity	5.58e-06	7.81e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—obesity	5.54e-06	7.75e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—DPYD—obesity	5.53e-06	7.74e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CD36—obesity	5.53e-06	7.73e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SREBF1—obesity	5.52e-06	7.73e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CPT1A—obesity	5.5e-06	7.7e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MTOR—obesity	5.41e-06	7.56e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CB—obesity	5.41e-06	7.56e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NAMPT—obesity	5.4e-06	7.55e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GOT2—obesity	5.37e-06	7.52e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GCK—obesity	5.36e-06	7.51e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LIPC—obesity	5.36e-06	7.51e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOC3—obesity	5.33e-06	7.46e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PRKAR2B—obesity	5.32e-06	7.45e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—obesity	5.3e-06	7.41e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—DCN—obesity	5.29e-06	7.4e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—FASN—obesity	5.26e-06	7.36e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MTHFR—obesity	5.24e-06	7.33e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—BCHE—obesity	5.23e-06	7.33e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—obesity	5.19e-06	7.27e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CETP—obesity	5.17e-06	7.24e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CPT1A—obesity	5.14e-06	7.19e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARA—obesity	5.14e-06	7.19e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SDC1—obesity	5.12e-06	7.16e-05	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	5.08e-06	7.11e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP2E1—obesity	5.05e-06	7.07e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NAMPT—obesity	5.04e-06	7.06e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKR1C3—obesity	5.03e-06	7.04e-05	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—obesity	5.02e-06	7.02e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—obesity	5.01e-06	7.01e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LIPC—obesity	5.01e-06	7.01e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GCK—obesity	5.01e-06	7.01e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NQO1—obesity	4.99e-06	6.99e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOC3—obesity	4.98e-06	6.97e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AGT—obesity	4.98e-06	6.96e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SCARB1—obesity	4.96e-06	6.93e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—obesity	4.94e-06	6.92e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—obesity	4.94e-06	6.91e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.89e-06	6.84e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOE—obesity	4.88e-06	6.82e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—obesity	4.85e-06	6.78e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CETP—obesity	4.83e-06	6.76e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CAV1—obesity	4.83e-06	6.76e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOA1—obesity	4.82e-06	6.74e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SREBF1—obesity	4.81e-06	6.73e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC2A4—obesity	4.79e-06	6.7e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GCG—obesity	4.79e-06	6.7e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SDC1—obesity	4.78e-06	6.69e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYCS—obesity	4.73e-06	6.61e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKR1C3—obesity	4.7e-06	6.58e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—obesity	4.7e-06	6.57e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GOT2—obesity	4.68e-06	6.55e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GGT1—obesity	4.64e-06	6.49e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GOT1—obesity	4.64e-06	6.49e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SCARB1—obesity	4.63e-06	6.48e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.61e-06	6.46e-05	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—obesity	4.59e-06	6.42e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—FASN—obesity	4.58e-06	6.41e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK8—obesity	4.57e-06	6.39e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NCOA1—obesity	4.57e-06	6.39e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	4.57e-06	6.39e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—BCHE—obesity	4.56e-06	6.38e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—obesity	4.56e-06	6.38e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	4.51e-06	6.31e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—STK11—obesity	4.5e-06	6.3e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP19A1—obesity	4.5e-06	6.3e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SREBF1—obesity	4.49e-06	6.29e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP2E1—obesity	4.4e-06	6.16e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CG—obesity	4.4e-06	6.16e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GOT2—obesity	4.37e-06	6.12e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NQO1—obesity	4.35e-06	6.09e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	4.31e-06	6.03e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—FASN—obesity	4.28e-06	5.99e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—BCHE—obesity	4.26e-06	5.96e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—obesity	4.25e-06	5.94e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—POMC—obesity	4.19e-06	5.86e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—COMT—obesity	4.18e-06	5.86e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—obesity	4.18e-06	5.85e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GCG—obesity	4.17e-06	5.84e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC2A4—obesity	4.17e-06	5.84e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—INS—obesity	4.16e-06	5.83e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GNB3—obesity	4.13e-06	5.77e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARGC1A—obesity	4.13e-06	5.77e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYCS—obesity	4.12e-06	5.76e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP2E1—obesity	4.11e-06	5.75e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMOX1—obesity	4.11e-06	5.75e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NQO1—obesity	4.06e-06	5.69e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GGT1—obesity	4.04e-06	5.65e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GOT1—obesity	4.04e-06	5.65e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GNAS—obesity	4.02e-06	5.62e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3.98e-06	5.57e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NCOA1—obesity	3.98e-06	5.57e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	3.94e-06	5.52e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOB—obesity	3.93e-06	5.51e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—STK11—obesity	3.92e-06	5.49e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP19A1—obesity	3.92e-06	5.49e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC2A4—obesity	3.9e-06	5.45e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GCG—obesity	3.9e-06	5.45e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MYC—obesity	3.88e-06	5.43e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—obesity	3.87e-06	5.42e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CD—obesity	3.87e-06	5.41e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYCS—obesity	3.85e-06	5.38e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—obesity	3.82e-06	5.34e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GGT1—obesity	3.77e-06	5.28e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GOT1—obesity	3.77e-06	5.28e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LPL—obesity	3.76e-06	5.26e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NCOA1—obesity	3.72e-06	5.2e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPX1—obesity	3.67e-06	5.13e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—STK11—obesity	3.66e-06	5.13e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP19A1—obesity	3.66e-06	5.13e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NOS3—obesity	3.65e-06	5.11e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3R1—obesity	3.65e-06	5.11e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CA—obesity	3.65e-06	5.11e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—COMT—obesity	3.65e-06	5.1e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GNB3—obesity	3.59e-06	5.03e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARGC1A—obesity	3.59e-06	5.03e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMOX1—obesity	3.58e-06	5.01e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CD36—obesity	3.57e-06	5e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GNAS—obesity	3.5e-06	4.9e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOB—obesity	3.43e-06	4.8e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—COMT—obesity	3.41e-06	4.77e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTHFR—obesity	3.38e-06	4.73e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CB—obesity	3.37e-06	4.72e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARGC1A—obesity	3.36e-06	4.7e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GNB3—obesity	3.36e-06	4.7e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMOX1—obesity	3.34e-06	4.68e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—obesity	3.34e-06	4.67e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARA—obesity	3.32e-06	4.64e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CA—obesity	3.3e-06	4.61e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LPL—obesity	3.27e-06	4.58e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GNAS—obesity	3.27e-06	4.58e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AGT—obesity	3.21e-06	4.5e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOB—obesity	3.2e-06	4.48e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPX1—obesity	3.19e-06	4.47e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOE—obesity	3.15e-06	4.41e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CAV1—obesity	3.12e-06	4.37e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOA1—obesity	3.11e-06	4.36e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CD36—obesity	3.11e-06	4.35e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPL—obesity	3.06e-06	4.28e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPX1—obesity	2.98e-06	4.17e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.98e-06	4.17e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—obesity	2.98e-06	4.17e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTHFR—obesity	2.95e-06	4.12e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—obesity	2.92e-06	4.08e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CD36—obesity	2.91e-06	4.07e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARA—obesity	2.89e-06	4.05e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CG—obesity	2.84e-06	3.98e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AGT—obesity	2.8e-06	3.92e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTHFR—obesity	2.75e-06	3.85e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOE—obesity	2.74e-06	3.84e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—obesity	2.74e-06	3.84e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CAV1—obesity	2.72e-06	3.8e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOA1—obesity	2.71e-06	3.8e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—POMC—obesity	2.71e-06	3.79e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARA—obesity	2.7e-06	3.78e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—obesity	2.69e-06	3.77e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—INS—obesity	2.69e-06	3.76e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AGT—obesity	2.62e-06	3.66e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOE—obesity	2.56e-06	3.59e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CAV1—obesity	2.54e-06	3.55e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA1—obesity	2.53e-06	3.55e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CD—obesity	2.5e-06	3.5e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CG—obesity	2.48e-06	3.46e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—obesity	2.47e-06	3.45e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.43e-06	3.39e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—obesity	2.39e-06	3.34e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NOS3—obesity	2.36e-06	3.3e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3R1—obesity	2.36e-06	3.3e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—POMC—obesity	2.36e-06	3.3e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—INS—obesity	2.34e-06	3.28e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CG—obesity	2.31e-06	3.24e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—obesity	2.23e-06	3.12e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—POMC—obesity	2.2e-06	3.08e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—INS—obesity	2.19e-06	3.06e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CB—obesity	2.18e-06	3.05e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CD—obesity	2.18e-06	3.05e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—obesity	2.16e-06	3.02e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—obesity	2.15e-06	3.01e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3R1—obesity	2.06e-06	2.88e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NOS3—obesity	2.06e-06	2.88e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CA—obesity	2.06e-06	2.88e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CD—obesity	2.03e-06	2.85e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—obesity	2.01e-06	2.81e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3R1—obesity	1.92e-06	2.69e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NOS3—obesity	1.92e-06	2.69e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CB—obesity	1.9e-06	2.65e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—obesity	1.88e-06	2.63e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CB—obesity	1.77e-06	2.48e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—obesity	1.76e-06	2.46e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—obesity	1.68e-06	2.35e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CA—obesity	1.33e-06	1.86e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CA—obesity	1.16e-06	1.62e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—obesity	1.08e-06	1.52e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CA—obesity	1.08e-06	1.51e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—obesity	9.45e-07	1.32e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—obesity	8.83e-07	1.24e-05	CbGpPWpGaD
